PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,585,198 | -10.6% | 1,310,048 | +23.5% | 0.21% | -0.5% |
Q2 2023 | $15,187,864 | +284.1% | 1,060,605 | +91.5% | 0.21% | +215.2% |
Q1 2023 | $3,954,339 | -36.1% | 553,829 | +0.4% | 0.07% | -42.6% |
Q4 2022 | $6,191,499 | +1.2% | 551,827 | -0.1% | 0.12% | +7.5% |
Q3 2022 | $6,121,000 | +30.4% | 552,442 | -0.7% | 0.11% | +27.4% |
Q2 2022 | $4,694,000 | -38.0% | 556,105 | -0.0% | 0.08% | +20.0% |
Q1 2022 | $7,571,000 | -29.5% | 556,293 | +1.9% | 0.07% | +14.8% |
Q4 2021 | $10,741,000 | -39.2% | 546,055 | -0.8% | 0.06% | -33.7% |
Q3 2021 | $17,663,000 | -4.5% | 550,240 | +0.7% | 0.09% | +1.1% |
Q2 2021 | $18,500,000 | -39.8% | 546,522 | -33.2% | 0.09% | -45.2% |
Q1 2021 | $30,739,000 | – | 818,385 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |